(+)-artemisinin multiple interactions EXP 6480464 artemisinin inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein], artemisinin inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 1,2-dimethylhydrazine affects expression ISO RGD:730827 6480464 1, 2-Dimethylhydrazine affects the expression of ESRRA mRNA CTD PMID:22206623 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ESRRA mRNA CTD PMID:15968320 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ESRRA mRNA, Estradiol results in increased expression of ESRRA protein CTD PMID:15223131 more ... 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of ESRRA mRNA CTD PMID:22574217 17beta-estradiol increases expression ISO RGD:1583866 6480464 Estradiol results in increased expression of ESRRA mRNA CTD PMID:12193582 , PMID:15458797 17beta-estradiol decreases expression ISO RGD:1583866 6480464 Estradiol results in decreased expression of ESRRA mRNA CTD PMID:15458797 17beta-estradiol multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased expression of ESRRA mRNA] more ... CTD PMID:15968320 more ... 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:730827 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:30796839 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:730827 6480464 Tetrachlorodibenzodioxin results in increased expression of ESRRA mRNA CTD PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1583866 6480464 Tetrachlorodibenzodioxin results in increased expression of ESRRA mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1583866 6480464 Tetrachlorodibenzodioxin results in decreased expression of ESRRA mRNA CTD PMID:32109520 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:730827 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,4,6-tribromophenol decreases expression EXP 6480464 2 more ... CTD PMID:31675489 2,4-dinitrotoluene affects expression ISO RGD:1583866 6480464 2, 4-dinitrotoluene affects the expression of ESRRA mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO RGD:1583866 6480464 2, 6-dinitrotoluene affects the expression of ESRRA mRNA CTD PMID:21346803 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of ESRRA protein CTD PMID:31675489 3,6-diaminoacridine multiple interactions EXP 6480464 Proflavine inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 Decitabine inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 8-Br-cAMP increases expression ISO RGD:730827 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ESRRA mRNA CTD PMID:23166782 afimoxifene multiple interactions EXP 6480464 afimoxifene binds to and results in decreased activity of [ESRRG protein binds to ESRRA protein] CTD PMID:14751226 afimoxifene affects binding EXP 6480464 afimoxifene binds to ESRRA protein mutant form CTD PMID:11447273 aflatoxin B1 increases expression ISO RGD:730827 6480464 Aflatoxin B1 results in increased expression of ESRRA mRNA CTD PMID:19770486 Aflatoxin B2 alpha increases methylation EXP 6480464 aflatoxin B2 results in increased methylation of ESRRA intron CTD PMID:30157460 aldehydo-D-glucose multiple interactions ISO RGD:730827 6480464 resveratrol inhibits the reaction [Glucose results in decreased expression of ESRRA protein] CTD PMID:23090186 aldehydo-D-glucose decreases expression ISO RGD:730827 6480464 Glucose results in decreased expression of ESRRA protein CTD PMID:23090186 alpha-naphthoflavone affects binding EXP 6480464 [alpha-naphthoflavone binds to AHR protein] which binds to ESRRA protein CTD PMID:10620335 aristolochic acid increases expression EXP 6480464 aristolochic acid I results in increased expression of ESRRA mRNA CTD PMID:33212167 atrazine increases expression ISO RGD:1583866 6480464 Atrazine results in increased expression of ESRRA mRNA CTD PMID:34600026 benzo[a]pyrene increases expression ISO RGD:730827 6480464 Benzo(a)pyrene results in increased expression of ESRRA mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of ESRRA 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:730827 6480464 Benzo(a)pyrene results in decreased expression of ESRRA mRNA CTD PMID:22228805 berberine multiple interactions EXP 6480464 Berberine inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 beta-naphthoflavone affects binding EXP 6480464 [beta-Naphthoflavone binds to AHR protein] which binds to ESRRA protein CTD PMID:10620335 biochanin A multiple interactions EXP 6480464 biochanin A binds to and results in increased activity of ESRRA protein, biochanin A promotes the reaction [ESRRA protein binds to PNRC1 protein] CTD PMID:14638870 biochanin A affects binding EXP 6480464 biochanin A binds to ESRRA protein mutant form CTD PMID:14638870 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1583866 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ESRRA promoter CTD PMID:23359474 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:730827 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A increases expression ISO RGD:730827 6480464 bisphenol A results in increased expression of ESRRA mRNA CTD PMID:25111128 , PMID:33221593 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ESRRA mRNA CTD PMID:30903817 bisphenol A multiple interactions EXP 6480464 bisphenol A inhibits the reaction [Tamoxifen results in increased expression of ESRRA mRNA] CTD PMID:30467747 bisphenol A decreases expression ISO RGD:1583866 6480464 bisphenol A results in decreased expression of ESRRA mRNA, bisphenol A results in decreased expression of ESRRA protein CTD PMID:24105817 bisphenol A multiple interactions ISO RGD:730827 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A increases expression ISO RGD:1583866 6480464 bisphenol A results in increased expression of ESRRA mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1583866 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ESRRA promoter CTD PMID:23359474 bisphenol A decreases activity EXP 6480464 bisphenol A results in decreased activity of ESRRA protein CTD PMID:24457025 bisphenol A decreases expression ISO RGD:730827 6480464 bisphenol A results in decreased expression of ESRRA mRNA CTD PMID:12233820 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ESRRA mRNA, bisphenol A results in increased expression of ESRRA protein CTD PMID:21831745 more ... bortezomib decreases expression EXP 6480464 Bortezomib results in decreased expression of ESRRA mRNA CTD PMID:20977926 bortezomib multiple interactions EXP 6480464 Bortezomib inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein], Bortezomib inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 carbon nanotube decreases expression ISO RGD:730827 6480464 Nanotubes, Carbon results in decreased expression of ESRRA mRNA CTD PMID:25620056 carfilzomib multiple interactions EXP 6480464 carfilzomib inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein], carfilzomib inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 carmustine increases expression EXP 6480464 Carmustine results in increased expression of ESRRA mRNA CTD PMID:15980968 CHIR 99021 increases expression ISO RGD:730827 6480464 Chir 99021 results in increased expression of ESRRA mRNA CTD PMID:29883716 chlormidazole multiple interactions EXP 6480464 chlormidazole inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein], chlormidazole inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 clenbuterol increases expression ISO RGD:730827 6480464 Clenbuterol results in increased expression of ESRRA mRNA CTD PMID:17446185 colforsin daropate hydrochloride increases expression EXP 6480464 Colforsin results in increased expression of ESRRA mRNA, Colforsin results in increased expression of ESRRA protein CTD PMID:20351196 cyazofamid increases activity EXP 6480464 cyazofamid results in increased activity of ESRRA protein CTD PMID:20143881 cyclophosphamide decreases expression ISO RGD:1583866 6480464 Cyclophosphamide results in decreased expression of ESRRA mRNA CTD PMID:27281708 cyclophosphamide increases expression ISO RGD:1583866 6480464 Cyclophosphamide results in increased expression of ESRRA mRNA CTD PMID:27281708 D-glucose multiple interactions ISO RGD:730827 6480464 resveratrol inhibits the reaction [Glucose results in decreased expression of ESRRA protein] CTD PMID:23090186 D-glucose decreases expression ISO RGD:730827 6480464 Glucose results in decreased expression of ESRRA protein CTD PMID:23090186 daidzein multiple interactions EXP 6480464 daidzein binds to and results in increased activity of ESRRA protein more ... CTD PMID:14638870 diazinon increases methylation EXP 6480464 Diazinon results in increased methylation of ESRRA gene CTD PMID:22964155 dibenz[a,h]anthracene increases expression ISO RGD:730827 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate multiple interactions ISO RGD:1583866 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ESRRA promoter CTD PMID:23359474 diethylstilbestrol multiple interactions EXP 6480464 Diethylstilbestrol binds to and results in decreased activity of ESRRA protein, Diethylstilbestrol inhibits the reaction [ESRRA protein results in increased expression of TFF1 mRNA] CTD PMID:11559547 diethylstilbestrol decreases expression ISO RGD:730827 6480464 Diethylstilbestrol results in decreased expression of ESRRA mRNA CTD PMID:22710028 endosulfan increases expression ISO RGD:1583866 6480464 Endosulfan results in increased expression of ESRRA mRNA CTD PMID:29391264 ethanol affects splicing ISO RGD:730827 6480464 Ethanol affects the splicing of ESRRA mRNA CTD PMID:30319688 etoposide multiple interactions EXP 6480464 Etoposide inhibits the reaction [XCT790 results in decreased activity of ESRRA protein], Etoposide promotes the reaction [PPARGC1A protein results in increased activity of ESRRA protein] CTD PMID:30818834 fenpyroximate multiple interactions EXP 6480464 fenpyroximate inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein], fenpyroximate inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 ferroheme b decreases expression ISO RGD:730827 6480464 Heme metabolite results in decreased expression of ESRRA mRNA CTD PMID:19191707 flavone multiple interactions EXP 6480464 flavone binds to and results in increased activity of ESRRA protein CTD PMID:14638870 flavone affects binding EXP 6480464 flavone binds to ESRRA protein mutant form CTD PMID:14638870 fluoxastrobin multiple interactions EXP 6480464 fluoxastrobin inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein], fluoxastrobin inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 fulvestrant multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [fulvestrant results in increased expression of ESRRA mRNA] more ... CTD PMID:15968320 , PMID:20211987 fulvestrant increases expression EXP 6480464 Fulvestrant results in increased expression of ESRRA mRNA, Fulvestrant results in increased expression of ESRRA protein CTD PMID:20211987 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of ESRRA mRNA CTD PMID:23777605 genistein multiple interactions EXP 6480464 Genistein binds to and results in increased activity of ESRRA protein, Genistein binds to and results in increased activity of ESRRA protein mutant form CTD PMID:14638870 , PMID:15955695 genistein decreases activity EXP 6480464 Genistein results in decreased activity of ESRRA protein CTD PMID:24457025 genistein increases expression EXP 6480464 Genistein results in increased expression of ESRRA mRNA CTD PMID:16399490 , PMID:23019147 glucose multiple interactions ISO RGD:730827 6480464 resveratrol inhibits the reaction [Glucose results in decreased expression of ESRRA protein] CTD PMID:23090186 glucose decreases expression ISO RGD:730827 6480464 Glucose results in decreased expression of ESRRA protein CTD PMID:23090186 heme b decreases expression ISO RGD:730827 6480464 Heme metabolite results in decreased expression of ESRRA mRNA CTD PMID:19191707 hydrogen peroxide multiple interactions ISO RGD:1583866 6480464 Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ESRRA protein], trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of ESRRA protein] CTD PMID:30104959 hydrogen peroxide decreases expression ISO RGD:1583866 6480464 Hydrogen Peroxide results in decreased expression of ESRRA protein CTD PMID:30104959 hydrogen peroxide multiple interactions EXP 6480464 ESRRA protein inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 protein] CTD PMID:24967384 indole-3-methanol affects expression ISO RGD:1583866 6480464 indole-3-carbinol affects the expression of ESRRA mRNA CTD PMID:21396975 isoflavones multiple interactions EXP 6480464 Isoflavones binds to and results in increased activity of ESRRA protein CTD PMID:14638870 isoflavones affects binding EXP 6480464 Isoflavones binds to ESRRA protein mutant form CTD PMID:14638870 kresoxim-methyl multiple interactions EXP 6480464 kresoxim-methyl inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein], kresoxim-methyl inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 lead(0) increases expression EXP 6480464 Lead results in increased expression of ESRRA mRNA CTD PMID:19921347 lead(2+) increases expression EXP 6480464 Lead results in increased expression of ESRRA mRNA CTD PMID:19921347 metformin multiple interactions ISO RGD:730827 6480464 Metformin inhibits the reaction [GCG protein results in increased expression of ESRRA mRNA] CTD PMID:23166782 metformin decreases expression ISO RGD:730827 6480464 Metformin results in decreased expression of ESRRA mRNA CTD PMID:23166782 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of ESRRA mRNA CTD PMID:17400583 methotrexate decreases response to substance EXP 6480464 ESRRA protein results in decreased susceptibility to Methotrexate CTD PMID:24967384 methotrexate multiple interactions EXP 6480464 ESRRA protein inhibits the reaction [Methotrexate results in increased cleavage of CASP7 protein] more ... CTD PMID:24967384 N-acetyl-L-cysteine multiple interactions ISO RGD:1583866 6480464 Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ESRRA protein] CTD PMID:30104959 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ESRRA mRNA, 1-Methyl-4-phenylpyridinium results in decreased expression of ESRRA protein CTD PMID:26141122 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 PPARGC1A protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of ESRRA mRNA], PPARGC1A protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of ESRRA protein] CTD PMID:26141122 oxybenzone decreases expression ISO RGD:1583866 6480464 oxybenzone results in decreased expression of ESRRA mRNA CTD PMID:15458797 ozone increases expression ISO RGD:1583866 6480464 Ozone results in increased expression of ESRRA mRNA CTD PMID:25838073 paracetamol affects expression ISO RGD:730827 6480464 Acetaminophen affects the expression of ESRRA mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1583866 6480464 Acetaminophen results in increased expression of ESRRA mRNA CTD PMID:33387578 paraquat decreases expression ISO RGD:730827 6480464 Paraquat results in decreased expression of ESRRA mRNA CTD PMID:12595580 paraquat increases expression ISO RGD:1583866 6480464 Paraquat results in increased expression of ESRRA mRNA CTD PMID:32680482 perfluorooctanoic acid increases expression ISO RGD:1583866 6480464 perfluorooctanoic acid results in increased expression of ESRRA mRNA CTD PMID:19616056 picoxystrobin multiple interactions EXP 6480464 picoxystrobin inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein], picoxystrobin inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1583866 6480464 Pregnenolone Carbonitrile results in increased expression of ESRRA mRNA CTD PMID:19162173 progesterone increases expression EXP 6480464 Progesterone results in increased expression of ESRRA mRNA CTD PMID:15968320 prostaglandin E2 multiple interactions EXP 6480464 6-isopropoxy-9-oxoxanthene-2-carboxylic acid inhibits the reaction [Dinoprostone results in increased expression of ESRRA mRNA] more ... CTD PMID:20351196 prostaglandin E2 increases expression EXP 6480464 Dinoprostone results in increased expression of ESRRA mRNA, Dinoprostone results in increased expression of ESRRA protein CTD PMID:20351196 pyridaben multiple interactions EXP 6480464 pyridaben inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein], pyridaben inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 resveratrol increases expression ISO RGD:730827 6480464 resveratrol results in increased expression of ESRRA mRNA, resveratrol results in increased expression of ESRRA protein CTD PMID:19934007 , PMID:23090186 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of ESRRA protein CTD PMID:24365713 resveratrol multiple interactions ISO RGD:730827 6480464 resveratrol inhibits the reaction [Glucose results in decreased expression of ESRRA protein], SIRT1 protein promotes the reaction [resveratrol results in increased expression of ESRRA mRNA] CTD PMID:19934007 , PMID:23090186 rotenone multiple interactions EXP 6480464 Rotenone inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein], Rotenone inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 T-2 toxin affects expression ISO RGD:1583866 6480464 T-2 Toxin affects the expression of ESRRA mRNA CTD PMID:29870751 tamoxifen multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tamoxifen results in increased expression of ESRRA mRNA] more ... CTD PMID:20211987 , PMID:30467747 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of ESRRA mRNA, Tamoxifen results in increased expression of ESRRA protein CTD PMID:20211987 , PMID:30467747 tebuconazole increases expression ISO RGD:1583866 6480464 tebuconazole results in increased expression of ESRRA mRNA, tebuconazole results in increased expression of ESRRA protein CTD PMID:33049508 testosterone increases expression ISO RGD:730827 6480464 Testosterone results in increased expression of ESRRA mRNA CTD PMID:19693291 testosterone multiple interactions EXP 6480464 Dinoprostone promotes the reaction [ESRRA protein promotes the reaction [Testosterone results in increased abundance of Estradiol]], ESRRA protein promotes the reaction [Testosterone results in increased abundance of Estradiol] CTD PMID:20351196 tetrachloroethene decreases expression ISO RGD:730827 6480464 Tetrachloroethylene results in decreased expression of ESRRA mRNA CTD PMID:28973375 thioacetamide increases expression ISO RGD:1583866 6480464 Thioacetamide results in increased expression of ESRRA mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 Topotecan inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein], Topotecan inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 toxaphene multiple interactions EXP 6480464 Toxaphene binds to and results in decreased activity of ESRRA protein more ... CTD PMID:10493499 more ... toxaphene decreases activity EXP 6480464 Toxaphene results in decreased activity of ESRRA protein CTD PMID:10493499 trichloroethene increases expression ISO RGD:1583866 6480464 Trichloroethylene results in increased expression of ESRRA mRNA CTD PMID:33387578 trichostatin A increases activity EXP 6480464 trichostatin A results in increased activity of ESRRA protein CTD PMID:11705994 trifloxystrobin multiple interactions EXP 6480464 trifloxystrobin inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein], trifloxystrobin inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 trifluridine multiple interactions EXP 6480464 Trifluridine inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 trilobatin multiple interactions ISO RGD:1583866 6480464 trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of ESRRA protein] CTD PMID:30104959 triptonide increases expression ISO RGD:730827 6480464 triptonide results in increased expression of ESRRA mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of ESRRA mRNA CTD PMID:20860658 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of ESRRA mRNA CTD PMID:25979313 vinclozolin decreases expression ISO RGD:1583866 6480464 vinclozolin results in decreased expression of ESRRA mRNA CTD PMID:23034163 vorinostat multiple interactions EXP 6480464 Vorinostat inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834